MRT(MRT)
MRT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $82M | $128M |
| Low | $69M | $101M |
| High | $92M | $155M |
| EBITDA Avg | $-453,323 | $30M |
| Low | $-4M | $29M |
| High | $4M | $31M |
| EBIT Avg | $-12M | $8M |
| Low | $-15M | $7M |
| High | $-7M | $8M |
| Net Income Avg | $-23M | $-3M |
| Low | $-26M | $-4M |
| High | $-18M | $-2M |
| EPS Avg | $-0.29 | $-0.04 |
| Low | $-0.33 | $-0.05 |
| High | $-0.23 | $-0.03 |
| Analysts (Rev / EPS) | 3 / 1 | 4 / 2 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $23M | $26M | $28M | $31M | $33M | $35M |
| Low | $23M | $26M | $28M | $30M | $33M | $34M |
| High | $23M | $26M | $28M | $31M | $34M | $35M |
| EBITDA Avg | $2M | $4M | $6M | $8M | $11M | $12M |
| Low | $1M | $3M | $6M | $8M | $11M | $12M |
| High | $2M | $4M | $6M | $8M | $11M | $12M |
| EBIT Avg | $390,931 | $2M | $4M | $5M | $7M | $8M |
| Low | $-39,729 | $821,591 | $4M | $5M | $7M | $7M |
| High | $821,591 | $3M | $4M | $5M | $7M | $8M |
| Net Income Avg | $-4M | $-3M | $-430,660 | $861,320 | $2M | $3M |
| Low | $-4M | $-3M | $-437,521 | $847,596 | $2M | $3M |
| High | $-3M | $-2M | $-423,798 | $875,043 | $2M | $3M |
| EPS Avg | $-0.04 | $-0.03 | $-0.01 | $0.01 | $0.03 | $0.03 |
| Low | $-0.05 | $-0.04 | $-0.01 | $0.01 | $0.02 | $0.03 |
| High | $-0.04 | $-0.02 | $-0.00 | $0.01 | $0.03 | $0.03 |
| Analysts (Rev / EPS) | 2 / 2 | 2 / 2 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |